Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).

Learn more about the comment process

AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 11 - 20 out of 46

AMIA Urges Feds to Think Beyond Traditional Care Boundaries for ‘Future Vision’ of Interoperability

March 15, 2019

In comments submitted to the National Science Foundation’s (NSF) Networking and Information Technology Research and Development Program (NITRD), AMIA supported their future vision for interoperability among medical devices, electronic health records, and other systems within the healthcare ecosystem. In doing so, AMIA observed that the future of interoperability will undoubtedly […]

HIPAA Must Better Promote Information Sharing, Urges AMIA

February 12, 2019

In comments submitted to the Department of Health & Human Services (HHS) Office of Civil Rights (OCR), AMIA recommended that the Office ensure that HIPAA both requires and permits information-sharing upon patient and clinician request, as well as robust penalties for failing to deliver data pursuant to the patient “right […]

AMIA Supports National Testing Collaborative for Health IT

December 20, 2018

In response to a Request for Information from the Centers for Disease Control and Prevention, AMIA urged HHS officials to focus on narrow use cases, such as CDS or eCQMs, when conceptualizing a national collaborative for health IT testing. AMIA also outlined the pros/cons of focusing on CDS versus eCQMs […]

AMIA Seeks Harmonization of Data Privacy Policies

November 9, 2018

In response to a Request for Comment from the National Telecommunications and Information Administration, AMIA urged the administration to seek harmonization of federal data privacy policies, while also ensuring that consumer access to and control over his or her data be the baseline for its policies.

AMIA Offers Input to ONC on Information Blocking

August 6, 2018

The following statement was released today by Douglas B. Fridsma, MD, PhD, FACP, FACMI, regarding a letter to ONC about information blocking:

Information blocking is the absence of interoperability, and there are numerous reasons why information may not flow as intended. Some of these reasons are technical, others for business […]

AMIA Provides FDA Lit Review on Risk and Benefits of Medical Software

June 28, 2018

AMIA responded to an FDA request for input with a preliminary review of relevant research into the specific benefits and risks to health associated with software functions that the 21st Century Cures Act excluded from the definition of medical device. While some health IT applications to healthcare delivery have unambiguously […]